Company / Operating Margin
Royalty Pharma plc Operating Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
65.6%
FY2025
5-year range
57.1% / 144.6%
FY2021-FY2025
Trend
+14.9%
vs FY2024
Sector context
#2 of 135
Health Care
What the data says
Among 135 Health Care companies, Royalty Pharma plc is in the top 1% for operating margin. Operating Margin returned to growth in FY2025 after 3 years of decline, reaching 65.6%.
Based on SEC 10-K filings.
65.6% in FY2025 with a 5-year CAGR of -10.4%. Ranks 2nd among 135 companies in Health Care.
Improved from 63.4% to 65.6% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -9.6pp
- 5-Year Change
- -10.4pp
- 10-Year Change
- -
Sector benchmark
Top 1% in Health CareTop 1% of 135This company 65.6% Sector average -774.4%
▼
+108.5% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 14.9% year-over-year.
- Currently 840.0pp above the Health Care sector average.
- Peak operating margin was recorded in FY2021.
- Lowest operating margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 65.6% | +14.9% |
| FY2024 | 57.1% | -9.9% |
| FY2023 | 63.4% | -15.7% |
| FY2022 | 75.2% | -48.0% |
| FY2021 | 144.6% | +90.2% |
| FY2020 | 76.0% | - |
| FY2019 | - | - |
| FY2018 | 76.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026